Groupe Athena Inc (GATA) 0.1700 $GATA Groupe Athena,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Groupe Athena Inc (GATA) 0.1700 $GATA

Groupe Athena, Inc. Releases Year End Financials, Posts Record Revenue
eTeligis - Mon Jul 20, 3:15PM CDT
MUMBAI, India, via ETELIGIS INC., 07/20/2015 - - Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), is very excited to post the results for their fiscal year ending June 30, 2015. Annual revenue for the period was $70,867,148 which is an increase of 9% over the previous fiscal year and represents another new benchmark for the company. EBITDA for the year was also strong at $8,185,170 and net after tax income for the period was $4,613,321 or $.10 per share.

Groupe Athena, Inc. Nominated for CFI.co Award
ACCESSWIRE - Fri Jun 12, 8:15AM CDT
MUMBAI, INDIA / ACCESSWIRE / June 12, 2015 / Groupe Athena, Inc. (PINKSHEETS: GATA) announced today that it is one of 3 companies nominated for the prestigious CFI.co award for best pharmaceutical consultancy company from India. The final award will be announced by end July, 2015.

Groupe Athena, Inc. Posts Strong 3rd Quarter Results
ACCESSWIRE - Tue Jun 09, 8:17AM CDT
MUMBAI, INDIA / ACCESSWIRE / June 9, 2015 / Groupe Athena, Inc. (PINKSHEETS: GATA), announced revenues of $16,000,519 for the period ending March 31, 2015, an increase of $1,528,894 over the same period in 2014. Gross earnings before depreciation, amortization and taxes were $1,883,122 and net income was $1,073,319 or $.023 per share.

Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project
ACCESSWIRE - Thu Feb 19, 7:16AM CST
MUMBAI, IN / ACCESSWIRE / February 19, 2015 / Groupe Athena, Inc. (OTC: GATA) (PINKSHEETS: GATA) announced today that the company has started Pharmacokinetic (PK) modeling as part of its preclinical studies in its continuing efforts to start production of Atorvastatin Calcium. Pharmacokinetic modeling is a mathematical technique for predicting the effect and efficacy of drug dosing over time. Broadly speaking, pharmacokinetic models describe how the body reacts to a drug in terms of absorption, distribution, metabolism, and excretion.

Groupe Athena, Inc. Announces Revenue Update
ACCESSWIRE - Tue Feb 17, 7:16AM CST
MUMBAI, IN / ACCESSWIRE / February 17, 2015 / Groupe Athena, Inc. (OTC: GATA) (PINKSHEETS: GATA), announced on September 23, 2013 that based on the orders in hand, the company expects to achieve total revenues of $70 million in the current fiscal. The company is on track to report revenue of $16.5 million for the current quarter, which would reflect a growth 14% over the corresponding quarter of the previous year.

Groupe Athena, Inc. Posts 2nd Quarter Results
ACCESSWIRE - Wed Jan 21, 8:57AM CST
MUMBAI, INDIA / ACCESSWIRE / January 21, 2015 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $19,005,429 for the period ending December 31, 2014, an increase of $1,043,977 over the same period in 2013. Operating income before Depreciation and Amortization was $2,845,789 and reflects a Research and Development charge of $428,659. Net income for the period was $1,859,924 or $.04 per share.

Groupe Athena, Inc. Posts Strong 1st Quarter Results, Sees Progress Toward Transition To Manufacturing
ACCESSWIRE - Mon Nov 17, 8:16AM CST
Mumbai, India / ACCESSWIRE / November 17, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $20,181,962 for the period ending September 30, 2014, which represents an increase of $1,419,373 over the same period in 2013. Gross income before depreciation, amortization and taxes was $1,423,850. Operating income before Depreciation and Amortization was $1,423,850 and reflects a Research and Development charge of $1,862,065.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's New Dashboard: Unpacking Data Insights

Updated Category News Views 32

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 0

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 57

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Bay Area to Host New Jerry Garcia Arts Center

Updated Category News Views 43

Celebrating a Legend in the Heart of San Francisco The Bay Area is set to become home to a vibrant new center dedicated to celebrating the multifaceted legacy of Jerry Garcia, Grateful Dead co-founder. Announced by the Garcia family, with the help of archival platform Starchive and project coordinator Christopher McCutcheon, the Jerry Garcia Music Arts Center promises to...

Continue Reading
Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Updated Category News Views 3

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 6

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading
GoDaddy Launches 'Ink Your Link' in NYC

Updated Category News Views 16

GoDaddy's Bold Stunt at the Big Apple In the noise of the New York Stock Exchange, everyone is abuzz with GoDaddy’s latest marketing push. Aptly titled 'Ink Your Link,' this campaign has NYC in its sights this weekend, targeting entrepreneurs and consumers alike. The plan is to open a unique pop-up in Manhattan where business owners can ink a temporary tattoo—a bold...

Continue Reading
Invisors Expands PayBill Suite for Staffing Efficiency

Updated Category News Views 41

Invisors Doubles Down on Workday Integration The winds of change are whispering in the Professional & Business Services sector as Invisors rolls out its enhanced PayBill Suite. This move isn't just another tick on some corporate checklist; it's a serious play to streamline the gnarly process of transitions that staffing firms face. Invisors is tying this suite tightly...

Continue Reading
Northern Virginia's Housing Inventory Surges Despite Market Pressures

Updated Category News Views 74

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Continue Reading
FRP Moto Unveils M3 Mini: High-Tech Wheelie, 55 MPH Speed

Updated Category News Views 15

Who knew that mini bikes could pack such a punch? Enter the M3 from the folks at FRP Moto. This isn't just another two-wheeler for the kiddie circuit. Nope, this one's got the juice to make even seasoned riders do a double take. We're talking electric power, a top speed of 55 mph, and some snazzy wheelie modes. A Look Under the Hood Get this – the M3 isn’t your...

Continue Reading

Top 5 Most Recently Viewed Articles

Clare Locke Advocates for Megan Thee Stallion in Defamation Case

Updated Category News Views 111

Clare Locke LLP Champions Megan Thee Stallion's Defamation Case Clare Locke LLP, a respected name in defamation law, has taken a bold step to support Megan Thee Stallion's pursuit of justice against Milagro Cooper. The firm has filed a motion for leave to present an amicus brief that specifically endorses Megan's effort to have a jury's defamation ruling reinstated. This...

Continue Reading
Bankers Signal Looming Economic Challenges Amid Uncertainty

Updated Category News Views 167

Bankers Signal Looming Economic Challenges Amid Uncertainty Interest rate fluctuations, credit quality, and tariffs are significant concerns for financial institutions. A recent survey highlights the anxiety among bankers regarding the economic climate and impending recession. Survey Highlights Economic Fears According to a survey from fintech IntraFi, which gathered...

Continue Reading
Dave Portnoy Questions Elon Musk Amid Tesla's Plummeting Stock

Updated Category News Views 162

Tesla's Stock Dilemma: Portnoy's Concerns Tesla’s stock, designated as TSLA, has recently experienced a significant decline, stirring up discussions among investors and enthusiasts alike. Dave Portnoy, the founder of Barstool Sports, has voiced his frustration regarding this situation, bringing forth some pointed questions about Elon Musk’s priorities. In a recent...

Continue Reading
Akropolis Group's Credit Rating Affirmed Amid Strategic Changes

Updated Category News Views 88

Akropolis Group’s Robust Credit Rating Amid Strategic Reassessments Renowned international credit rating agency S&P Global Ratings recently evaluated the financial outlook for Akropolis Group, a prominent player in the real estate development and management sector. This assessment took into account significant structural governance changes within the Vilniaus Prekyba...

Continue Reading
Arcutis Takes a Significant Step with ZORYVE Cream for Kids

Updated Category News Views 156

Arcutis Advances ZORYVE® Cream for Pediatric Use Arcutis Biotherapeutics, Inc. is making headlines with its recent submission of a supplemental New Drug Application (sNDA) aimed at expanding the use of ZORYVE (roflumilast) cream 0.3% to treat plaque psoriasis in children as young as 2 years old. If approved, ZORYVE would be the first topical PDE4 inhibitor specifically...

Continue Reading